Sera of 27 members of 3 human kindreds with familial systemic lupus erythematosus (SLE) were examined for expression of a cross-reactive idiotype present on anti-DNA antibodies of SLE patients.
Introduction
The pathogenesis of systemic lupus erythematosus (SLE)' appears to be multifactorial, including both hormonal and environmental influences (1) . An important role for a genetic predisposition to SLE has been established by epidemiological analysis and studies of monozygotic twins (2) . Patients with SLE demonstrate a significantly increased frequency of major histocompatibility complex antigens HLA-DR2, HLA-DR3, and MTl; however, studies of disease patterns in families with SLE suggest that additional genetic factors are involved. Thus, the molecular basis for the genetic susceptibility remains unclear (3) .
Because SLE is a disease characterized by the production of autoantibodies, it is reasonable to ask whether the genetic predisposition might be related to the genes encoding these molecules. Recent studies demonstrate that the anti-DNA antibodies of unrelated SLE patients share cross-reactive idiotypes. The identification of shared structural features in anti-DNA antibodies suggests that a restricted number of germ line genes may encode these autoantibodies (4, 5) . We have previously described a monoclonal antibody, 31, which recognizes a cross-reactive idiotype on anti-DNA antibodies (6) . Hightitered 31 reactivity is found in over 85% of patients with SLE. While normal individuals do show low-titered expression of 31-reactive antibodies, less than 1% of normal individuals have high titered expression. We describe here the use of this antiidiotype to examine the sera of members of three human kindreds with familial SLE to determine (a) whether idiotype expression can be correlated with the presence of anti-DNA antibodies and with disease, and (b) whether isoelectric focusing gels of idiotypic antibodies reveal differences between idiotypic antibodies that have anti-DNA activity and those that do not.
Methods
Serum samples. Serum samples were obtained from SLE patients (defined by revised American Rheumatism Association criteria) (7) and their family members. Family I has two members with SLE; P.J. has renal involvement, E.U.J. does not. Clinical data on families 2 and 3 have previously been described (8) . M.A.F. in family 2 had autoimmune thyroiditis, B.L. in family 3 had idiopathic thrombocytopenic purpura. Several family members have, on some occasion, had anti-nuclear antibodies in their serum. In this study sera were studied without respect to the clinical status of the patient. Normal sera were obtained from healthy volunteers; none of the volunteers were in contact with SLE patients or sera. All sera were heat-inactivated at 60'C for 30 min. SLE patients and their family members were HLA typed by Dr. A. Gibofsky and Dr. R. Winchester and these data have been previously reported (8, 9) .
Assays for 31 reactivity. Sera were tested for reactivity with 31 by radioimmunoassay (6) . Sera at a 1:1,000 dilution were plated in microtiter wells (Immulon 2; Dynatech Laboratories, Inc., Alexandria, VA) and reacted with 31 culture supernatant followed by [135S]methionine-labeled antibody to mouse kappa chains. Isoelectric focusing and Western blot transfer were performed. The nitrocellulose blots were incubated with 31 supernatant and 31-reactive bands were revealed by peroxidase staining as previously described (10) . Precipitates of DNA-anti-DNA antibodies were redissolved in 8 M urea and similarly analyzed (see below).
Assays for anti-DNA activity. A modification of the Millipore filter method was used to detect anti-DNA reactivity (1 1 Western blot transfer were performed as previously described (10) .
The nitrocellulose blot was blocked for 90 min with 3% bovine serum albumin-saline, and then incubated with 2 X 107 cpm of [3"Simethionine-labeled 3I supernatant in 10 ml for 90 min and exposed for 16 h.
Results
Genealogies of the three families. In family 1, the affected individuals are female; in family 2, male; and in family 3, there are both males and a female with SLE. Of the patients with SLE, P.J., K.F., T.L.J., and P.L. have nephritis. The presence of anti-DNA antibodies and high-titer 31 reactivity did not appear to correlate with HLA-haplotype in any of the three families ( Fig. 1 ). Only in family I are there unaffected individuals with anti-DNA activity detectable by Millipore filter assay. Interestingly, both these individuals are male, while the clinically affected members of the family are female. 3I reactivity. By radioimmunoassay, 6 of 8 patients with familial SLE and 15 of 19 family members without SLE had high-titered 31 reactivity (Fig. 2) . One additional SLE patient, T.L.J., had borderline elevated 3I reactivity. In each of the three families, there were unaffected individuals with hightitered idiotype expression. To determine if there was any difference between the 3I-reactive antibodies of SLE patients and those of unaffected family members, we displayed the serum samples on isoelectric focusing gels and analyzed the 31-reactive antibodies on Western blots. This analysis revealed two patterns of 31 reactivity: in one, 31-reactive bands were restricted to the pH range 5-7, and in the other, there were additional cationic 3I-reactive bands at pH 7-8.5 (Figs. 3, 4 , and 5). SLE patients showed both patterns of reactivity. Patients P.J., K.F., P.L., and T.L.J. had 31-reactive antibodies predominantly in the pH range 5-7; patients E.U.J., E.F.J., T.L.S., and M.E.L. had cationic 31-reactive antibodies as well. Most unaffected family members showed only the first pattern whether high-titered 3I reactivity was present in their serum or not. However, four unaffected family members (B.J., F.J., M.I.J., and M.A.F.), all with high-titer 3I reactivity, had cationic 31-positive antibodies present by Western blot analysis. While some of the individuals with cationic bands had very high-titer 31 reactivity (e.g., F.J. and E.U.J.), others had only moderate elevations in 31 reactivity (e.g., B.J. and T.L.S. anti-DNA antibodies, which are revealed by Western blot analysis (Figs. 7 and 8) . However, the other 11 family members with high-titered 3I reactivity failed to reveal anti-DNA antibodies present either in free or in masked form. Only the unaffected family members with anti-DNA antibodies, free or masked, had cationic 31-reactive bands (F.J., B.J., and M.I.J. from family 1 in Figs. 3 and 7 ; M.A.F. from family 2 in Figs. 4 and 8), suggesting that the acquisition of DNA reactivity may be associated with a difference in charge.
DNA-anti DNA precipitates. The sera of SLE patient E.U.J., the four unaffected family members with anti-DNA antibodies (F.J., B.J., M.I.J., and M.A.F.), and one normal individual were tested to see which sera formed precipitates with DNA in vitro, a finding thought to be correlated with pathogenicity (13). Precipitating anti-DNA antibodies were found for all but the normal serum. Ouchterlony analysis revealed predominantly both IgG and IgM antibodies in the precipitates formed from F.J. and B.J. serum. The DNA anti-DNA precipitates were tested for 31 reactivity on Western blots of isoelectric focusing gels and all were found to include 31-reactive anti-DNA antibodies (Fig. 10) like syndrome has revealed the existence of such cross-reactive idiotypes (14) (15) (16) . More surprisingly, analysis of anti-DNA antibodies from unrelated patients with SLE has likewise revealed the existence of cross-reactive idiotypes. Cross-reactive idiotypes occur also on anti-acetylcholine receptor antibodies in myasthenia gravis (17) , antithyroglobulin antibodies in autoimmune thyroiditis (18) , and anti-RO/SSA antibodies in families with complement (C2) deficiency (19) , suggesting that a restricted number of germ line genes encode the pathogenic antibodies in many autoimmune diseases.
We have previously reported a monoclonal antiidiotype, 31, which recognizes a cross-reactive idiotype on human anti-DNA antibodies in a majority of patients with SLE (6) . This idiotype is expressed in low titer in normal individuals and in high titer in SLE patients. Because the 31 anti-idiotype is not directed to the DNA-binding site, it is able to detect anti-DNA antibodies in lupus serum which are masked in conventional antigen-binding assays, presumably either by excess antigen or by autologous antiidiotype.
In the present study we have examined the expression of this cross-reactive idiotype in kindreds with familial lupus. We have found that family members without SLE have hightitered idiotype expression, and that cationic idiotypic antibodies have increased affinity for DNA. 6 of 8 SLE patients and 15 of 19 family members have elevated expression of the 31 idiotype; one additional SLE patient has borderline elevated reactivity. Those sera with elevated 31 reactivity but no anti-DNA antibodies have 31-reactive bands focusing at pH 5-7.
Cationic 31-reactive antibodies were found only in sera with anti-DNA antibodies, whether from SLE patients or from clinically unaffected family members. Thus the cationic charge of 31-reactive immunoglobulin appears to be associated with increased affinity for DNA. We do not know if this is the case for all anti-DNA antibodies but it appears to be so for 31-reactive anti-DNA antibodies. While there are anti-DNA antibodies that are not cationic and 31-reactive antibodies that are not cationic, the 31-reactive antibodies that precipitate with DNA almost all focus at pH > 7 (Fig. 10) . It has been suggested that cationic anti-DNA antibodies are preferentially deposited in the kidney, perhaps because they bind to polyanionic sites in glomerular basement membrane (20). Our data suggest that cationic anti-DNA antibodies may be more pathogenic also because of increased affinity for DNA.
In 1 SLE patient and 11 relatives, high-titered 31 reactivity was not associated with anti-DNA antibodies, masked or unmasked. In these sera there were no cationic 31-reactive antibodies. In this study we report single serum samples, and it is possible that both the SLE patients and some of the family members may have anti-DNA antibodies present at other times as many of them intermittently have anti-nuclear antibodies. However, it is clear from this study that idiotype expression can be dissociated from DNA-binding activity.
In our study, four family members without SLE were found to have anti-DNA antibodies; one of these, M.A.F., had a history of autoimmune thyroiditis. Two were very high titer by conventional anti-DNA assay and two were unmasked by analysis under dissociating conditions. They all had precipitating antibodies of the IgG class which were cationic on isoelectric focusing gels, characteristics which have been reported to correlate with increased antibody pathogenicity. Therefore, the relationship between autoreactive antibodies and autoimmune disease remains to be defined. It is rare to find anti-DNA antibodies present in normal individuals; however, the presence of anti-DNA antibodies in healthy relatives, both blood related and nonblood related, of patients with SLE has been reported (21) . Whether these individuals without SLE chronically have anti-DNA antibodies present in their serum and whether they will go on to develop overt disease is a matter of great interest.
It is of interest that, in our study, some spouses (M.A.F. and K.L.) had high-titered reactivity with the 31 antiidiotypic antibody. M.A.F. had cationic 31-reactive antibodies and anti-DNA activity. K.L. had 31-reactive antibodies focusing at pH < 7 and no anti-DNA activity. It is not known ifthey exhibited elevated expression of the 31 idiotype before their cohabitation with SLE patients or if they acquired high-titered 31 reactivity thereafter. It is possible that both spouses are exposed to a common environmental antigen and respond by producing 31-reactive antibodies. Alternatively, the fact that both spouses have high-titered 3I reactivity need not reflect a common exposure to antigen but merely a coincidentally shared genetic predisposition to utilize particular germ line genes. In this context we note that M.A.F. has an unrelated autoimmune disease, Hashimoto's thyroiditis. We do not know whether the expression of 31 is increased in this disease. loses affinity for phosphorylcholine and acquires reactivity with DNA and other phosphorylated macromolecules (26) . While it is possible that different germ line genes encode 31-reactive DNA-binding and 31-reactive non-DNA-binding antibodies or that the 31-reactive chain is linked to a different heavy chain in each case, it may be that somatic mutation converts a 3I-positive non-DNA-binding immunoglobulin into a 31-positive anti-DNA antibody. If this occurs, our data suggests that this may be associated with a change in charge such that the DNA-binding 31-reactive antibody becomes more cationic.
That a genetic predisposition towards development of SLE exists is now well established. In previous studies of SLE, disease has been associated with HLA haplotype. In this study there was no association of HLA haplotype with either disease or idiotype expression, a finding similar to that of Pasquali et al. (23) . It is interesting to speculate, on the basis of the data reported here, that the genetic predisposition to SLE may reflect, in part, the use of particular immunoglobulin variable regions, such as the one encoding 31-reactive immunoglobulins, used to make antibodies against bacteria or other commonly encountered antigens. Regulation of expression of the 31 idiotype may be under genetic control. Those with high-titered 31 reactivity may express more of this idiotype in response to microbial antigens. Randomly occurring somatic mutations may then convert 31-positive non-DNA-binding antibodies into idiotype-positive anti-DNA antibodies. These mutations may be associated with a change in charge of the idiotypepositive immunoglobulins. Some variable regions used in making anti-bacterial antibodies may require a larger number of mutations to become anti-DNA antibodies, while others, such as 31-reactive antibodies, may be only a few mutations away from autoreactivity and therefore be more likely to form autoantibodies. Individuals with high-titered 31 reactivity may thus be more likely to develop 31-reactive anti-DNA antibodies than individuals without high-titered 3I reactivity.
